Fig. 2From: Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case seriesSerum creatinine concentrations before treatment, at 1 month after initiation of AMK, at 3 months after initiation of AMK, and at the end of treatmentBack to article page